Browse our anti-ABL1 (ABL1) Antibodies

Full name:
anti-C-Abl Oncogene 1, Non-Receptor tyrosine Kinase Antibodies (ABL1)
On www.antibodies-online.com are 637 C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) Antibodies from 29 different suppliers available. Additionally we are shipping ABL1 Proteins (39) and ABL1 Kits (12) and many more products for this protein. A total of 746 ABL1 products are currently listed.
Synonyms:
Abl, ABL1, ABLL, AI325092, bcr/abl, c-Abl, CABL, cb272, E430008G22Rik, JTK7, MTP, p150, v-abl
list all antibodies Gene Name GeneID UniProt
ABL1 25 P00519
ABL1 11350 P00520
ABL1 311860  

Show all species

Show all synonyms

Most Popular Reactivities for anti-ABL1 (ABL1) Antibodies

Select your species and application

anti-Human ABL1 Antibodies:

anti-Mouse (Murine) ABL1 Antibodies:

anti-Rat (Rattus) ABL1 Antibodies:

All available anti-ABL1 Antibodies

Go to our pre-filtered search.

Top referenced anti-ABL1 Antibodies

  1. Human Polyclonal ABL1 Primary Antibody for DB, IHC (p) - ABIN389501 : Barnes, McIntosh, Whetton, Daley, Bentley, Baldwin: Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. in Oncogene 2005 (PubMed)
    Show all 6 references for 389501

  2. Human Polyclonal ABL1 Primary Antibody for DB, IF - ABIN389865 : Kim, Cho, Yoon, Park, Kim, Lee, Chun, Kim, Lee et al.: Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra ... in Genes, chromosomes & cancer 2005 (PubMed)
    Show all 5 references for 389865

  3. Human Polyclonal ABL1 Primary Antibody for WB - ABIN389507 : Cao, Leng, Liu, Yi, Li, Kufe: Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. in Biochemistry 2003 (PubMed)
    Show all 4 references for 389507

  4. Human Polyclonal ABL1 Primary Antibody for ELISA, WB - ABIN1532033 : Fainstein, Einat, Gokkel, Marcelle, Croce, Gale, Canaani: Nucleotide sequence analysis of human abl and bcr-abl cDNAs. in Oncogene 1990 (PubMed)
    Show all 3 references for 1532033

  5. Human Polyclonal ABL1 Primary Antibody for IF, ELISA - ABIN1531424 : Chissoe, Bodenteich, Wang, Wang, Burian, Clifton, Crabtree, Freeman, Iyer, Jian: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. in Genomics 1995 (PubMed)
    Show all 3 references for 1531424

  6. Mouse (Murine) Polyclonal ABL1 Primary Antibody for IHC (p), WB - ABIN657828 : Ko, Lee, Shin, Karuppagounder, Gadad, Koleske, Pletnikova, Troncoso, Dawson, Dawson: Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. in Proceedings of the National Academy of Sciences of the United States of America 2010 (PubMed)
    Show all 2 references for 657828

  7. Human Polyclonal ABL1 Primary Antibody for IF, IHC (p) - ABIN392080 : Donaldson, Gish, Pawson, Kay, Forman-Kay: Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. in Proceedings of the National Academy of Sciences of the United States of America 2002 (PubMed)

  8. Human Polyclonal ABL1 Primary Antibody for IF, IHC - ABIN1531765 : Krapivinsky, Medina, Krapivinsky, Gapon, Clapham: SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. in Neuron 2004 (PubMed)

More Antibodies against ABL1 Interaction Partners

Human C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. We demonstrate that nanopore technology is suitable for employment in the hematology laboratory for detecting BCR (show BCR Antibodies)-ABL1 kinase domain mutation in Philadelphia-positive leukemias.

  2. Data suggest that amphipathic beta-strands in 200 N-terminal residues of beta1 domain of APOB (show APOB Antibodies) are required for secretion of lipid-rich or lipid-poor particles; residues 300-700 or 1050-1500 of beta1 domain appear to be required for secretion of lipid-rich particles; MTTP (show MTTP Antibodies) is required for secretion of intact APOB (show APOB Antibodies) but not of truncated APOB (show APOB Antibodies). (APOB (show APOB Antibodies) = apolipoprotein B (show APOB Antibodies); MTTP (show MTTP Antibodies) = microsomal triglyceride transfer protein (show MTTP Antibodies))

  3. Frequent molecular monitoring and intervention are required for patients who do not show a reduction in BCR (show BCR Antibodies)-ABL1 transcripts to these levels after stem cell transplantation.

  4. c-Abl promotes TGF-beta (show TGFB1 Antibodies)-induced SKIP/Smad3 (show SMAD3 Antibodies) interaction.

  5. Data indicate the feasibility of detecting ABL1 mutations in cerebrospinal fluid (CSF (show CSF2 Antibodies)) by next-generation sequencing (NGS) in patients with central nervous system relapse in BCR (show BCR Antibodies)-ABL1-positive acute lymphoblastic leukemia.

  6. the e13a2 BCR (show BCR Antibodies)-ABL1 fusion transcript affects the rate, the depth, and the speed of the response to treatment with imatinib firstline, and that including the transcript type in the calculation of the baseline risk scores may improve prognostic stratification and may help the choice of the best treatment policy.

  7. Normal ABL1 is a tumor suppressor in BCR (show BCR Antibodies)-ABL1-induced leukemia. Allosteric stimulation of the normal ABL1 kinase (show BCR Antibodies) activity enhanced the antileukemia effect of ABL1 tyrosine kinase inhibitors.

  8. the ABL family of tyrosine kinases rheostatically enhances IRE1alpha's enzymatic activities, thereby potentiating endoplasmic reticulum stress-induced apoptosis.

  9. 6 overexpression may contribute to the high proliferation and low apoptosis in chronic myeloid leukemia (show BCL11A Antibodies) cells and can be regulated by BCR/ABL signal transduction through downstream phosphoinositide 3-kinase/Akt (show AKT1 Antibodies) and Janus kinase/signal transducer and activator of transcription (show STAT1 Antibodies) pathways, suggesting cell division cycle protein 6 as a potential therapeutic target in chronic myeloid leukemia (show BCL11A Antibodies).

  10. ETV6 (show ETV6 Antibodies)-ABL1 fusion occurs in both lymphoid and myeloid leukemias; the genomic profile and clinical behavior resemble BCR (show BCR Antibodies)-ABL1-positive malignancies, including the unfavorable prognosis, particularly of acute leukemias. The poor outcome suggests that treatment with tyrosine kinase (show TXK Antibodies) inhibitors should be considered for patients with this fusion.

Mouse (Murine) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. this study shows that signaling downstream of murine inhibitory receptors does not involve c-Abl and that c-Abl plays no major role in NK cell education in the mouse

  2. ABL potentiated the assembly and activation of the RUNX2 (show RUNX2 Antibodies)-TAZ (show TAZ Antibodies) master transcription factor complex that is required for osteoblastogenesis, while antagonizing PPARgamma (show PPARG Antibodies)-mediated adipogenesis.

  3. Normal ABL1 is a tumor suppressor in BCR (show BCR Antibodies)-ABL1-induced leukemia. ABL1 inhibits expansion and proliferation of BCR (show BCR Antibodies)-ABL1-expressing leukemic stem cells. Allosteric stimulation of the normal ABL1 kinase activity enhanced the antileukemia effect of ABL1 tyrosine kinase (show TYRO3 Antibodies) inhibitors.

  4. the ABL family of tyrosine kinases rheostatically enhances IRE1alpha's enzymatic activities, thereby potentiating endoplasmic reticulum stress-induced apoptosis.

  5. p38a (show MAPK14 Antibodies) as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38a (show MAPK14 Antibodies).

  6. Our data show that: i) HDAC2 (show HDAC2 Antibodies) levels and activity are increased in NPC (show NPC1 Antibodies) neuronal models and in Npc1 (show NPC1 Antibodies)(-/-) mice; ii) inhibition of c-Abl or c-Abl deficiency prevents the increase of HDAC2 (show HDAC2 Antibodies) protein levels and activity in NPC (show NPC1 Antibodies) neuronal models

  7. The resistance in BCR (show BCR Antibodies)-ABL1 cells resulted either from the Y253H mutation in the BCR (show BCR Antibodies)-ABL1 gene or incubation in increasing concentrations of imatinib.

  8. These results reveal a new pathway in the DNA damage response wherein ABL-dependent tyrosine phosphorylation of DGCR8 (show DGCR8 Antibodies) stimulates the processing of selective primary miRNAs.

  9. These findings connect the EphB signaling pathway to the regulation of intestinal adenoma initiation via Abl kinase.

  10. overexpression of Id2 in primary alveolar epithelial cells promotes proliferation by inhibiting a retinoblastoma protein/c-Abl interaction leading to greater c-Abl activity.

Caenorhabditis elegans (C. elegans) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. MIG-13 (show DHPS Antibodies)-WAVE pathway provides the major force for directional cell motility, whereas MIG-13 (show DHPS Antibodies)-WASP (show WASL Antibodies) partially compensates for its loss, underscoring their coordinated activities in facilitating robust cell migration.

  2. By screening candidate genes involved in Eph (show EPHA1 Antibodies) signaling, we find that the Eph (show EPHA1 Antibodies) kinase-independent pathway involves the ABL-1 nonreceptor tyrosine kinase (show TYRO3 Antibodies) and possibly the phosphatidylinositol 3-kinase pathway

  3. The trade-off in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys (show LYZ Antibodies)-7 and the tyrosine kinase abl-1.

  4. oxidative, osmotic, heat shock and starvation stresses induce germ cell apoptosis through a p53 (show TP53 Antibodies) and EGL-1 independent pathway; the MAPK (show MAPK1 Antibodies) kinases MEK-1 (show MAP2K1 Antibodies) and SEK-1 (show MAP2K4 Antibodies), and the p53 (show TP53 Antibodies) antagonist protein ABL-1, are essential for stress-induced germ cell apoptosis

  5. findings demonstrate that ABL-1, the C. elegans homolog of the mammalian c-Abl nonreceptor tyrosine kinase (show TYRO3 Antibodies) ABL1, is required for Shigella flexneri pathogenesis in nematodes

ABL1 Antigen Profile

Antigen Summary

MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia.

Alternative names and synonyms associated with ABL1

  • c-abl oncogene 1, receptor tyrosine kinase (ABL1) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (ABL1) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (abl2) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (Abl1) antibody
  • microsomal triglyceride transfer protein (MTTP) antibody
  • Protein ABL-1 (abl-1) antibody
  • Abl antibody
  • ABL1 antibody
  • ABLL antibody
  • AI325092 antibody
  • bcr/abl antibody
  • c-Abl antibody
  • CABL antibody
  • cb272 antibody
  • E430008G22Rik antibody
  • JTK7 antibody
  • MTP antibody
  • p150 antibody
  • v-abl antibody

Protein level used designations for ABL1

c-abl oncogene 1, receptor tyrosine kinase , v-abl Abelson murine leukemia viral oncogene homolog 1 , Abelson murine leukemia viral (v-abl) oncogene homolog 1 , v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) , tyrosine kinase ABL , Abelson murine leukemia viral (v-abl) oncogene homolog 2 , Abelson tyrosine-protein kinase 2 , arg, Abelson-related , tyrosine-protein kinase ABL2 , v-abl Abelson murine leukemia viral oncogene homolog 2 , arg tyrosine kinase , tyrosine-protein kinase ABL2-like , Abelson tyrosine-protein kinase 1 , bcr/c-abl oncogene protein , proto-oncogene c-Abl , proto-oncogene tyrosine-protein kinase ABL1 , tyrosine-protein kinase ABL1 , Abelson murine leukemia oncogene , abelson murine leukemia viral oncogene homolog 1 , p150 , v-abl Abelson murine leukemia oncogene 1 , v-abl Abelson murine leukemia viral oncogene 1 , microsomal triglyceride transfer protein (large polypeptide, 88kDa) , microsomal triglyceride transfer protein large subunit

GENE ID SPECIES
280970 Bos taurus
417181 Gallus gallus
464802 Pan troglodytes
491292 Canis lupus familiaris
395410 Gallus gallus
457552 Pan troglodytes
511845 Bos taurus
570636 Danio rerio
717037 Macaca mulatta
100348328 Oryctolagus cuniculus
100463896 Ailuropoda melanoleuca
100543723 Meleagris gallopavo
100588798 Nomascus leucogenys
25 Homo sapiens
540876 Bos taurus
11350 Mus musculus
311860 Rattus norvegicus
4547 Homo sapiens
181261 Caenorhabditis elegans
Selected quality suppliers for anti-ABL1 (ABL1) Antibodies
Did you look for something else?